Skip to content
conftrace_
2026 MIDL MIDL 2026

CARE: Confidence-aware Ratio Estimation for Medical Biomarkers

Ratio-based biomarkers (RBBs), such as the proportion of necrotic tissue within a tumor, are widely used in clinical practice to support diagnosis, prognosis, and treatment planning. These biomarkers are typically estimated from segmentation outputs by computing region-wise ratios. Despite the high-stakes nature of clinical decision making, existing methods provide only point estimates, offering no measure of uncertainty. In this work, we propose a unified confidence-aware framework for estimating ratio-based biomarkers. Our uncertainty analysis stems from two observations: (1) the probability ratio estimator inherently admits a statistical confidence interval regarding local randomness (bias and variance); (2) the segmentation network is not perfectly calibrated (calibration error). We perform a systematic analysis of error propagation in the segmentation-to-biomarker pipeline and identify model miscalibration as the dominant source of uncertainty. Extensive experiments show that our method produces statistically sound confidence intervals, with tunable confidence levels, enabling more trustworthy application of segmentation-derived RBBs in clinical workflows. Codes:

🌉 Interdisciplinary Bridge - Artificial Intelligence and Healthcare & Medicine

More from MIDL 2026

All MIDL 2026 papers →